# Johnson & Johnson to sell LifeScan to Platinum Equity for $2.1B

Johnson & Johnson accepted a binding offer from Platinum Equity to acquire its LifeScan business for approximately $2.1 billion. LifeScan is a blood glucose monitoring company and maker of OneTouch products.

- Type: Acquisition
- Announced: 2018-07-13
- Where: United States
- Value: $2.10B
- Status: announced
- Products: blood glucose monitoring systems, OneTouch brand products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Platinum Equity](https://endata.com/companies/1087.md) (acquirer)
- [Johnson & Johnson](https://endata.com/companies/9845.md) (target)
- [LifeScan](https://endata.com/companies/30790.md) (target)

## Sources

- [medicalbuyer.co.in](https://medicalbuyer.co.in/jj-accepts-binding-offer-from-platinum-equity-to-acquire-lifescan/), 2018-07-13: "Johnson and Johnson has accepted the binding offer from Platinum Equity, previously announced on March 16, 2018, to acquire its LifeScan business for approximately USD 2.1 billion."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.